Mitsubishi UFJ Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$88.7K Buy
36,185
+14,300
+65% +$35K ﹤0.01% 1031
2025
Q1
$146K Buy
21,885
+1,689
+8% +$11.3K ﹤0.01% 991
2024
Q4
$254K Buy
20,196
+8,190
+68% +$103K ﹤0.01% 957
2024
Q3
$222K Sell
12,006
-1,112
-8% -$20.5K ﹤0.01% 954
2024
Q2
$282K Buy
13,118
+2,217
+20% +$47.7K ﹤0.01% 924
2024
Q1
$294K Sell
10,901
-489
-4% -$13.2K ﹤0.01% 921
2023
Q4
$327K Sell
11,390
-2,087
-15% -$59.9K ﹤0.01% 965
2023
Q3
$276K Buy
13,477
+981
+8% +$20.1K ﹤0.01% 993
2023
Q2
$248K Sell
12,496
-3,896
-24% -$77.4K ﹤0.01% 1015
2023
Q1
$281K Buy
16,392
+973
+6% +$16.7K ﹤0.01% 985
2022
Q4
$295K Sell
15,419
-9,786
-39% -$188K ﹤0.01% 979
2022
Q3
$402K Buy
25,205
+444
+2% +$7.08K ﹤0.01% 923
2022
Q2
$341K Buy
24,761
+13,200
+114% +$182K ﹤0.01% 982
2022
Q1
$183K Buy
11,561
+932
+9% +$14.8K ﹤0.01% 1070
2021
Q4
$252K Buy
10,629
+3,043
+40% +$72.1K ﹤0.01% 1043
2021
Q3
$227K Buy
7,586
+211
+3% +$6.31K ﹤0.01% 1042
2021
Q2
$327K Sell
7,375
-3,287
-31% -$146K ﹤0.01% 1027
2021
Q1
$473K Buy
10,662
+3,525
+49% +$156K ﹤0.01% 900
2020
Q4
$391K Sell
7,137
-2,998
-30% -$164K ﹤0.01% 860
2020
Q3
$232K Buy
10,135
+115
+1% +$2.63K ﹤0.01% 880
2020
Q2
$210K Sell
10,020
-1,542
-13% -$32.3K ﹤0.01% 887
2020
Q1
$161K Buy
11,562
+2,397
+26% +$33.4K ﹤0.01% 874
2019
Q4
$204K Buy
9,165
+713
+8% +$15.9K ﹤0.01% 868
2019
Q3
$98K Buy
8,452
+1,585
+23% +$18.4K ﹤0.01% 908
2019
Q2
$103K Sell
6,867
-4,146
-38% -$62.2K ﹤0.01% 913
2019
Q1
$193K Buy
11,013
+814
+8% +$14.3K ﹤0.01% 808
2018
Q4
$153K Buy
10,199
+3,598
+55% +$54K ﹤0.01% 784
2018
Q3
$163K Buy
+6,601
New +$163K ﹤0.01% 792